Ravindre Panchia

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

Myron S. Cohen, Ying Qing Chen, Marybeth McCauley et al. · New England Journal of Medicine · 2016 · 1.7K citations · Full text

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo et al. · The Lancet Infectious Diseases · 2014 · 507 citations · Full text

Hptn 052, Hiv/aids Counselling, Treatment And Prevention +8

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock et al. · The Lancet · 2022 · 498 citations · Full text

Sexual Health, Phase 3, Treatment And Prevention +9

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Linda‐Gail Bekker, Moupali Das, Quarraisha Abdool Karim et al. · New England Journal of Medicine · 2024 · 358 citations

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

Mark F. Cotton, Avy Violari, Kennedy Otwombe et al. · The Lancet · 2013 · 257 citations

Pediatric Epidemiology, Treatment And Prevention, Hiv Early Antiretroviral +7